Cancer Management and Research (Sep 2023)
Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction]
Abstract
Liang X, Xu C, Cao X, Wang W. Cancer Manag Res. 2019;11:8923–8936. We, the Editors and Publisher of Cancer Management and Research, have retracted the following article. Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images from Figure 2 with images from another article. Specifically, The western blot image for Figure 2J, DNMT1, has been duplicated with the image for Figure 3h, CD44, from Liang X, Xu C, Wang W, Li X, The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. Stem Cells Int. 2019;2019:7028901. https://doi.org/10.1155/2019/7028901. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As the findings could not be verified the Editor and Publisher made the decision to retract the article and the authors were notified of this. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
